FDA Approves NGS-Based Companion Diagnostic for EGFR Exon20

The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific's Oncomine Dx Target Test as a companion diagnostic (CDx) to help identify non-small cell lung cancer (NSCLC) patients whose tumors carry epidermal growth factor receptor (EGFR) Exon20-insertion mutations for ...

Related Keywords

Japan , South Korea , Singapore , Garret Hampton , J Thorac Oncolo , Unity Lab Services , Janssen Biotech Inc , Ministry Of Health , Drug Administration , Thermo Fisher , Fisher Scientific , Thermo Fisher Scientific Inc , Our Mission , Oncomine Dx Target Test , Thermo Fisher Scientific , Janssen Biotech , Middle East , Thermo Scientific , Applied Biosystems , Important Safety Information , International Association , Lung Cancer , Lung Cancer Singapore , Worldwide Virtual ,